Search alternatives:
significant mean » significant main (Expand Search), significant green (Expand Search), significant gap (Expand Search)
shape decrease » shape increases (Expand Search), small decrease (Expand Search), step decrease (Expand Search)
teer decrease » greater decrease (Expand Search)
significant mean » significant main (Expand Search), significant green (Expand Search), significant gap (Expand Search)
shape decrease » shape increases (Expand Search), small decrease (Expand Search), step decrease (Expand Search)
teer decrease » greater decrease (Expand Search)
-
161
-
162
-
163
-
164
Summary of post-treatment disease course measures from off-label medications clinical trials.
Published 2025Subjects: -
165
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
Published 2025Subjects: -
166
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
Published 2025Subjects: -
167
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
Published 2025Subjects: -
168
-
169
-
170
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
Published 2025Subjects: -
171
-
172
-
173
-
174
-
175
-
176
-
177
B2 decreases glycolytic intermediates in cells.
Published 2025“…Other abbreviations: HGA, DL-hydroxyglutaric acid; PEP, phosphoenolpyruvic acid; 3-PGA, 3-phosphoglyceric acid; G3P; glyceraldehyde 3-phosphate; Data (n = 5) are shown as mean±SD. Not significant (ns): **<i>P</i> ≤ 0.01, ****<i>P</i> ≤ 0.0001by one-way ANOVA with multiple comparison of the mean of each test group to the mean of the vehicle control. …”
-
178
-
179
Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration.
Published 2025“…<p><b>(A)</b> A significant decrease in the proliferative clonal capacity of U87MG colonies was observed with 70ΜM and 100ΜM SHG-44 treatment. …”
-
180